Institutional members access full text with Ovid®

Share this article on:

Type 1 Cryoglobulinemia: Response to Thalidomide and Lenalidomide

Calabrese, Cassandra DO*; Faiman, Beth MSN, CNP; Martin, David MD; Reu, Frederic MD; Calabrese, Leonard H. DO§

JCR: Journal of Clinical Rheumatology: April 2011 - Volume 17 - Issue 3 - p 145-147
doi: 10.1097/RHU.0b013e3182155e8d
Concise Reports

From the *Ohio University of Osteopathic Medicine; †Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Foundation; ‡Internal Medicine, Northeastern Ohio University College of Medicine; and §Cleveland Clinic Lerner College of Medicine, Cleveland, OH.

The authors declare no conflicts of interest.

Correspondence: Leonard H. Calabrese, DO, Cleveland Clinic Foundation, Institute of Rheumatologic and Immunologic Diseases, Mail Code A50, 9500 Euclid Ave, Cleveland, OH 44195. E-mail: calabrl@ccf.org.

© 2011 Lippincott Williams & Wilkins, Inc.